NASDAQ:STAB

Statera Biopharma Stock Forecast

etoro logo Buy STAB
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jul 24, 2026
AI Analysis AI Analysis of STAB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add STAB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Statera Biopharma, Inc. stock after losing 0%
(Updated on Jul 24, 2026)

Buy or Hold candidate since Jun 17, 2026

No changes to the price of Statera Biopharma, Inc. stock on the last trading day (Friday, 24th Jul 2026). During the last trading day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.00008186900052 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -13.79% during the next 3 months and, with a 90% probability hold a price between $0.0000705762990 and $0.0003 at the end of this 3-month period.

STAB Signals & Forecast

The Statera Biopharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.0001 and $0.00009999999991. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 25, 2026, and so far it has risen 0.00000300000009%. Further rise is indicated until a new top pivot has been found. Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Statera Biopharma, Inc. stock

Statera Biopharma, Inc. finds support from accumulated volume at $0.0001000000 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%.

Our recommended stop-loss: $0.000094 (-6.00%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 20 days ago.)

Trading Expectations (STAB) For The Upcoming Trading Day Of Monday 27th

For the upcoming trading day on Monday, 27th we expect Statera Biopharma, Inc. to open at $0.0001, and during the day (based on 14 day Average True Range), to move between $0.00009747171289 and $0.0001, which gives a possible trading interval of +/-$0.00000505657423 (+/-5.19%) up or down from last closing price. If Statera Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 5.19% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $0.0001000000, some $0.0000000000 (0.00%) from the current price of $0.0001, our system finds the risk reward attractive.

Is Statera Biopharma, Inc. stock A Buy?

Statera Biopharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 27, 2026 - $0.0001 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

STAB Performance

Trading levels for STAB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0001 -
R2 0.0001 -
R1 0.0001 -
Price 0.0001
S1 0.0001 -
S2 0.0001 -
S3 0.0001 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 0.0001
S1 0.0001000000 -0.000003%
S2 0 -
S3 0 -

FAQ

What is the symbol for Statera Biopharma, Inc. Stock and on which exchange is it traded?
The symbol for Statera Biopharma, Inc. is STAB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Statera Biopharma, Inc. Stock?
Statera Biopharma, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Statera Biopharma, Inc. Stock?
Statera Biopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Statera Biopharma, Inc. Stock.

What's the current price of Statera Biopharma, Inc. Stock?
As of the end of day on the Jul 24, 2026, the price of an Statera Biopharma, Inc. (STAB) share was $0.0001.

What is the 52-week high and low for Statera Biopharma, Inc. Stock?
The 52-week high for Statera Biopharma, Inc. Stock is $0.0006 and the 52-week low is $0.000001.

What is the market capitalization of Statera Biopharma, Inc. Stock?
As of the Jul 24, 2026, the market capitalization of Statera Biopharma, Inc. is 7.142K.
Click to get the best stock tips daily for free!
ABOUT STATERA BIOPHARMA, INC.
Statera Biopharma
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential imm...
GOLDEN STAR
Ticker Change Signal Date
KMT
$34.39
2.44% Jul 21
DHT
$17.31
6.59% Jul 13
NMRK
$15.02
2.46% Jun 24
JLL
$299.78
8.56% Jun 24
ROP
$331.60
10.78% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE